Back to Search
Start Over
Method comparison of tumor markers assessed by LOCI™- and ECLIA-based technologies.
- Source :
- Journal of Laboratory Medicine / Laboratoriums Medizin; Feb2017, Vol. 41 Issue 1, p3-11, 9p
- Publication Year :
- 2017
-
Abstract
- The article offers information on measurement of tumors using luminescent oxygen channeling immunoassays (LOCI™)-based assays and electrochemiluminiscent immunoassays (ECLIA). Topics discussed include determination of prostate cancer using prostate-specific antigen (PSA) and free PSA (fPSA); use of chemiluminescence immunoassay in LOCI™ technology; and correlations between α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and prostate-specific antigen (PSA).
Details
- Language :
- English
- ISSN :
- 03423026
- Volume :
- 41
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Journal of Laboratory Medicine / Laboratoriums Medizin
- Publication Type :
- Academic Journal
- Accession number :
- 121234435
- Full Text :
- https://doi.org/10.1515/labmed-2016-0074